UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 19, 2004
Hawkins, Inc.
(Exact name of registrant as specified in its charter)
Minnesota | | 0-7647 | | 41-0771293 |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
|
3100 East Hennepin Avenue
Minneapolis, MN | | 55413 |
(Address of principal executive offices) | | (Zip Code) |
| | | | | | |
Registrant’s telephone number, including area code (612) 331-6910
Item 7. Exhibits.
99 Press Release dated February 19, 2004
Item 9. Regulation FD Disclosure.
On February 19, 2004, Hawkins, Inc. (“Hawkins”) reached a tentative settlement of its previously announced litigation relating to its pharmaceutical business. See Hawkins’ press release dated February 19, 2004, which is furnished as Exhibit 99 hereto and incorporated by reference in this Current Report on Form 8-K.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HAWKINS, INC. |
| | |
| | |
Date: February 20, 2004 | By | /s/ Marvin E. Dee | |
| | Marvin E. Dee |
| | Vice President, Chief Financial Officer, |
| | Secretary and Treasurer |
3
Index to Exhibits
Exhibit
Number | | Description | | Method of Filing |
99 | | Press Release dated February 19, 2004 | | Electronic Transmission |
4
